| 3-PK | phosphokinase |
| AET | aerobic exercise training |
| AGE | advanced glycation end-products |
| AR | aldose reductase |
| beta-MHC | beta-myosin heavy chain |
| BNP | type B natriuretic peptide |
| CK-MB | creatine kinase myocardial band |
| CO | cardiac output |
| DCM | diabetic cardiomyopathy |
| DM | diabetes mellitus |
| ECM | extracellular matrix |
| eNOS | endothelial nitric oxide synthase |
| ERK | extracellular signal-regulated kinases |
| ET-1 | endothelin-1 |
| FA | fatty acids |
| GLUT-4 | Glucose transporter type 4 |
| HAND | heart autonomic nervous system and neural crest derivatives |
| HbA1c | Hemoglobin A1c |
| HF | heart failure |
| HFpEF | heart failure with preserved ejection fraction |
| HFpEF | heart failure with reduced ejection fraction |
| HKII | hexokinase II |
| HR | heart rate |
| IR | Ischemia/Reperfusion |
| IRI | Ischemia Reperfusion Injury |
| JAK | Janus kinase |
| LV | left ventricle |
| MEF-2 | myogenic enhancer factor-2 |
| MS | metabolic syndrome |
| mTOR | mammalian target of rapamycin |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NO | nitric oxide |
| NOX2 | NADPH oxidase 2 |
| O-GlcNAc | O-Linked β-N-acetylglucosamine |
| PCI | percutaneous coronary intervention |
| per-RIC | perconditioning RIC |
| PKC | protein kinase C |
| PMI | periprocedural myocardial infarct |
| post-RIC | postconditioning RIC |
| pre-RIC | preconditioning RIC |
| PTEN | Phosphatase and tensin homolog deleted on chromosome 10 |
| RAGE | receptor for AGE |
| RIC | Remote ischemic conditioning |
| RISK | Reperfusion Injury Salvage Kinases |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| RT | resistance training |
| SAFE | Survivor Activating Factor Enhancement |
| SDH | sorbitol dehydrogenase |
| Smad | small mother against decapentaplegic |
| SMIT1 | sodium/myo-inositol cotransporter-1 |
| STAT-3 | signal transducer and activator of transcription 3 |
| SV | stroke volume |
| SVR | systemic vascular resistance |
| T1DM | type 1 diabetes mellitus |
| T2DM | type 2 diabetes mellitus |
| TGF-β | Transforming growth factor beta |
| TLR | Toll-like receptor |
| TNF-α | Tumor necrosis factor-α |
| VEGF | vascular endothelial growth factor |